Cargando…
Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics
Patients with cancer are an especially vulnerable population to potential drug-drug interactions (DDIs). This makes it important to adequately screen them for DDIs. The objective of this study was to compare the abilities of nine DDI screening tools to detect clinically relevant interactions with or...
Autores principales: | Marcath, Lauren A., Xi, Jingyue, Hoylman, Emily K., Kidwell, Kelley M., Kraft, Shawna L., Hertz, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797246/ https://www.ncbi.nlm.nih.gov/pubmed/29787332 http://dx.doi.org/10.1200/JOP.18.00086 |
Ejemplares similares
-
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
por: Marcath, Lauren A., et al.
Publicado: (2018) -
Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
por: Marcath, Lauren A., et al.
Publicado: (2021) -
Financial Impact of Medically Integrated Pharmacy Interventions on Oral Oncolytic Prescriptions
por: Darling, Julianne O., et al.
Publicado: (2022) -
2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard
por: Mackler, Emily, et al.
Publicado: (2019) -
Prescription drug monitoring and drug overdose mortality
por: Li, Guohua, et al.
Publicado: (2014)